P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1 STUDY

Detalles Bibliográficos
Autores principales: Lin, Y., Martin, T., Berdeja, J. G., Jakubowiak, A., Agha, M., Cohen, A. D., Deol, A., Htut, M., Lesokhin, A., Munshi, N. C., O’Donnell, E., Jackson, C. C., Yeh, T.-M., Banerjee, A., Zudaire, E., Madduri, D., Zhou, C., Pacaud, L., Usmani, S. Z., Jagannath, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431190/
http://dx.doi.org/10.1097/01.HS9.0000846712.74284.0f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431190/
http://dx.doi.org/10.1097/01.HS9.0000846712.74284.0f

Ejemplares similares